scholarly article | Q13442814 |
P50 | author | Philip Hoelter | Q48342223 |
Hagen B Huttner | Q90059383 | ||
P2093 | author name string | Stefan Schwab | |
Arnd Dörfler | |||
Hannes Lücking | |||
Joji B Kuramatsu | |||
Stefan T Gerner | |||
Jochen A Sembill | |||
Manuel Hagen | |||
Maximilian I Sprügel | |||
Sebastian S Roeder | |||
Dominik Madžar | |||
P2860 | cites work | Hematoma Expansion in ICH: Targeting Epidemiology or Biology? | Q92506567 |
Heparin for prophylaxis of venous thromboembolism in intracerebral haemorrhage | Q93137496 | ||
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage: Systematic Review and Analysis of MISTIE, CLEAR-IVH, and CLEAR III | Q26799042 | ||
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association | Q28262545 | ||
A trial of imaging selection and endovascular treatment for ischemic stroke | Q30417276 | ||
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials | Q31048053 | ||
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage | Q34778643 | ||
Warfarin-related intraventricular hemorrhage: imaging and outcome | Q35599518 | ||
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke | Q36837191 | ||
CTA Spot Sign Predicts Hematoma Expansion in Patients with Delayed Presentation After Intracerebral Hemorrhage | Q37000461 | ||
Endovascular treatment for acute ischemic stroke | Q37003026 | ||
Predictors of hematoma volume in deep and lobar supratentorial intracerebral hemorrhage. | Q37256620 | ||
Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage | Q37692398 | ||
Intracerebral hemorrhage location and outcome among INTERACT2 participants | Q37745068 | ||
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. | Q38415781 | ||
Intracerebral Hemorrhage Location and Functional Outcomes of Patients: A Systematic Literature Review and Meta-Analysis | Q38830132 | ||
Small intracerebral hemorrhages have a low spot sign prevalence and are less likely to expand. | Q40090628 | ||
Severity assessment in maximally treated ICH patients: The max-ICH score | Q40134227 | ||
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage | Q45081496 | ||
Racial variations in location and risk of intracerebral hemorrhage | Q46859642 | ||
Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage | Q46864838 | ||
Association of prothrombin complex concentrates administration and hematoma enlargement in NOAC-related intracerebral hemorrhage | Q47191525 | ||
Influence of Prior Nicotine and Alcohol Use on Functional Outcome in Patients after Intracerebral Hemorrhage | Q47571001 | ||
Early hemorrhage growth in patients with intracerebral hemorrhage | Q48821770 | ||
Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves | Q52807848 | ||
The ABCs of measuring intracerebral hemorrhage volumes. | Q54430652 | ||
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. | Q55395487 | ||
Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data | Q56888033 | ||
Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage | Q57156116 | ||
Antiplatelet Therapy in Primary Spontaneous and Oral Anticoagulation-Associated Intracerebral Hemorrhage | Q57789159 | ||
The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics | Q62343301 | ||
Intracerebral hemorrhage--improving outcome by reducing volume? | Q81277471 | ||
Location of intracerebral haemorrhage predicts haematoma expansion | Q90112540 | ||
Association of Surgical Hematoma Evacuation vs Conservative Treatment With Functional Outcome in Patients With Cerebellar Intracerebral Hemorrhage | Q90588245 | ||
Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations | Q91055064 | ||
Hematoma Expansion Differences in Lobar and Deep Primary Intracerebral Hemorrhage | Q91525109 | ||
Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage | Q91972057 | ||
Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage | Q92046626 | ||
P433 | issue | 3 | |
P304 | page(s) | 363-374 | |
P577 | publication date | 2020-03-04 | |
P1433 | published in | Annals of clinical and translational neurology | Q27725312 |
P1476 | title | Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage | |
P478 | volume | 7 |
Search more.